Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 898123 | ISIN: US9418481035 | Ticker-Symbol: WAZ
Tradegate
12.05.26 | 21:05
299,60 Euro
-0,13 % -0,40
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
WATERS CORPORATION Chart 1 Jahr
5-Tage-Chart
WATERS CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
299,80300,4012.05.
297,80302,0012.05.

Aktuelle News zur WATERS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.05.Waters forecasts 2026 adjusted EPS of $14.40 to $14.60 as it raises organic growth outlook to 6.5% to 8%4
05.05.Waters hebt Prognose an und übertrifft Erwartungen - Aktie legt kräftig zu10
WATERS Aktie jetzt für 0€ handeln
05.05.Waters Q1 2026 slides: acquisition drives revenue surge, synergies ahead3
05.05.Waters Aktie: Übernahme-Skeptiker stumm geschaltet - Mega-Beat!9
05.05.Waters Q1 Revenue Surges On Acquisitions, Expects Q2 Sales To Jump; Ups Annual Adj. Profit Outlook299WASHINGTON (dpa-AFX) - Waters Corporation (WAT), a provider of analytical instruments, diagnostics technologies, scientific software, and others, on Tuesday posted a net loss for the first quarter....
► Artikel lesen
05.05.Waters (WAT) Beats Q1 Earnings and Revenue Estimates5
05.05.Waters beats top-line and bottom-line estimates; introduces Q2 and raises FY26 outlook6
05.05.Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results426First Quarter 2026 HighlightsTotal reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and...
► Artikel lesen
05.05.WATERS CORP /DE/ - 8-K, Current Report1
04.05.Waters vor dem Quartalsbericht: Integration von BD im Fokus der Anleger4
20.04.Waters Corporation Schedules First Quarter 2026 Earnings Conference Call412MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live...
► Artikel lesen
15.04.Waters Corporation's Q1 2026 Earnings: What to Expect15
15.04.Waters Corporation: Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis462Achieves a ~3-hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy.First-of-its-kind blood volume...
► Artikel lesen
14.04.Waters Corporation: Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules337Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3Achieves 10x improvement in absolute molar mass and extended...
► Artikel lesen
10.04.Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics1.231THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations...
► Artikel lesen
08.04.Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit2
08.04.Waters wins FDA nod for at-home cervical cancer screening kit3
08.04.Waters Announces FDA Clearance Of Onclarity Self-Collection Kit For At-home Use350WASHINGTON (dpa-AFX) - Waters (WAT) announced that the FDA has cleared the Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use....
► Artikel lesen
08.04.Waters receives FDA clearance for at-home HPV screening kit3
08.04.Waters Corporation: Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay262FDA-approved BD Onclarity HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection...
► Artikel lesen
Weiter >>
107 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1